Interleukin-10 in dermatology;Interleukin-10 in der dermatologie

Hautarzt

Volumn 50, Issue 1, 1999, Pages 12-19

  Asadullah, Khusru ^a   Döcke, Wolf Dietrich ^a   Sabat, Robert ^a   Ebeling, Merle ^a   Volk, Hans Dieter ^a   Sterry, Wolfram ^a   Charité, Hautklinik Der ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Cytokines; IL 10; Inflammation; Psoriasis

Indexed keywords

INTERLEUKIN 10;

HUMAN; IMMUNOREGULATION; PATHOPHYSIOLOGY; PSORIASIS; REVIEW; SKIN DISEASE; SKIN TUMOR;

HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; PSORIASIS; SKIN DISEASES;

EID: 0344528635     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050858     Document Type: Review

References (89)

1. Abel EA, DiCicco LM, Orenberg EK, Fraki JE, Farber EM (1986) Drugs in exacerbation of psoriasis. J Am Acad Dermatol 15:1007-1022
2. Asadullah K, Döcke WD, Ebeling M, Friedrich M, Belbe G, Audring H, Volk HD, Sterry W (1998): IL-10 treatment of psoriasis - clinical results of a Phase II trial. Arch Dermatol in press
3. 2a. Asadullah K, Döcke WD, Haeußler A, Sterry W, Volk HD (1996) Progression of mycosis fungoides is associated with increasing cutaneous expression of IL-10-mRNA. J Invest Dermatol 107:833-837
4. Asadullah K, Döcke WD, Reinke P, Volk HD (1997) Zytokinbestimmungen-Diagnostischer Einsatz aus klinisch-immunologischer Sicht. Dtsch Med Wochenschr 122:1424-143
5. Asadullah K, Friedrich M, Döcke WD, Jahn S, Volk HD, Sterry W (1997) Enhanced expression of T-cell activation and natural killer cell antigens indicates systemic antitumor response in early primary cutaneous T-cell lymphoma (CTCL). J Invest Dermatol 108:743-747
6. Asadullah K, Renz H, Döcke WD, Otterbach H, Wahn U, Köttgen E, Volk HD, Sterry W (1997) Verrucosis of hand and feet in a patient with combined immune deficiency. J Am Acad Dermatol 36:850-852
7. Asadullah K, Schmid H, Friedrich M, Randow F, Volk HD, Sterry W, Döcke WD (1997) Influence of monomethylfumarate on monocytic cytokine formation - explanation for adverse and therapeutic effects in psoriasis? Arch Dermatol Res 289:623-630
8. Asadullah K, Stephanek K, Leupold M, Jasulaitis D, Audring H,Volk HD, Sterry W, Döcke WD (1998) IL-10 is a key cytokine in psoriasis: proof of principle by IL-10 therapy - a new therapeutic approach. J Clin Invest (in press)
9. Bécherel PA, LeGoff L, Ktorza S, Ouaaz F, Mencia-Huerta JM, Dugas B, Debré P, Mossalayi MD, Arock M (1995) Interleukin-10 inhibits IgE-mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytes. Eur J Immunol 25:2992-2995
10. Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J, Favrot C (1993) Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood 82:2169-2174
11. Böhm I, Bauer R (1997)Th1-Zellen, Th2-Zellen und atopische Dermatitis. Hautarzt 48:223-227
12. Boyd AS, Morris LF, Phillips CM, Menter MA (1996) Psoriasis and pregnancy: hormone and immune system interaction. Int J Dermatol 35:169-172
13. Braun-Falco O, Plewig G, Wolf HH (1995) Dermatologie und Venerologie. Springer, Berlin Heidelberg New York, S 448-460
14. Carson WE, Lindemann MJ, Baiocchi R, Linett M, Tan JC, Chou CC, Narula S, Caligiuri MA (1995) The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 85:3577-3585
15. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S (1994) Interleukin-10 upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 179:1695-1699
16. Chan SC, Li SH, Hanifin JM (1993) Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine-monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition. J Invest Dermatol 100:681-684
17. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, Kennedy JS, Rabson AR,Wolff SM, Dinarello CA (1995) A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 154:5492-5499
18. Cortes JE, Talpaz M, Cabanillas F, Seymour JF, Kurzrock R (1995) Serum levels of Interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis. Blood 85:2516-2520
19. D'Andrea A, Aste-Amezaga M,Valiante NM, Ma X, Kubin M, Trinchieri G (1993) Interleukin 10 (IL10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041-1048
20. Das NS, Chowdary TN, Sobhanadri C, Rao KV (1978) The effect of topical isoprenaline on psoriatic skin. Br J Dermatol 99:197-200
21. DeWaal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10 (1L10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220
22. De Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression. J Exp Med 174:915-924
23. Dummer R, Heald PW, Nestle FO, Ludwig E, Laine E, Hemmi S, Burg G (1996) Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor 1 (interferon-γrezeptor β-chain). Blood 88:1383-1389
24. Dummer W, Bastian BC, Ernst N, Schnalze C, Schwaaf A, Broker EB (1996) Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions. Int J Cancer 66:607-610
25. Enk AH, Angeloni VL, Udey MC, Katz SI (1993) Inhibition of Langerhans cell antigen-presenting function by IL-10. J Immunol 151:2390-2398
26. Enk AH, Katz SI (1992) Identification and induction of keratinocyte-derived IL-10. J Immunol 149:92-95
27. Enk CD, Sredni D, Blauvelt A, Katz S (1995) Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. J Immunol 154:4851-4856
28. Finbloom DS, Winestock KD (1995) IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol 155:1079-1090
29. Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse T-helper cell. IV. TH2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081-2095
30. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991 ) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822
31. Fiorentino DF, Zlotnik A,Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A (1991) IL-10 acts on antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444-3451
32. Fleming SB, McCaughan CA, Andrews AE, Nash AD, Mercer AA (1997) A homolog of interleukin-10 is encoded by the poxvirus orf virus. J Virol 71:4857-4861
33. Gilhar A, Grossman N, Kahanovicz S, Reuveni H, Cohen S, Eitan A (1996) Antiproliferative effect of pentoxifylline on psoriatic and normal epidermis. Acta Derm Venereol (Stockh) 76:437-441
34. Grewe M, Gyufko K, Krutmann J (1995) Interleukin-10 production by human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation. J Invest Dermatol 104:3-6
35. Hart PH, Hunt EK, Bonder CS, Watson CJ, Finlay-Jones JJ (1996) Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol 157:3672-3680
36. Ho AS, Liu Y, Khan TA, Hsu DH, Bazan JF, Moore KW (1993) A receptor for interleukin 10 is related to interferon receptors. Proc Natl Acad Sci U S A 90:11267-11271
37. Jenkins JK, Malyak M, Arend WP (1994) The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils. Lymphokine Cytokine Res 13:47-54
38. Jurlander J, Lai CF, Tan J, Chou CC, Geisler CH, Schriber J, Blumenson LE, Narula SK, Baumann H, Caligiuri MA (1997) Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. Blood 89:4146-4152
39. KÄgi MK, Wüthrich B, Montano E, Barandun J, Blaser K, Walker C (1994) Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals. Int Arch Allergy Immunol 103:332-340
40. Kang K, Hammerberg C, Meunier L, Cooper KD (1994) CD11b+ macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J Immunol 153:5256-5264
41. Kim J, Modlin RL, Moy RL, Dubinett SM, McHugh T, Nickoloff BJ, Uyemura K (1995) IL-10 production in cutaneous basal and squamous cell carcinomas. J Immunol 155:2240-2247
42. Kondo S, McKenzie RC, Sauder DN (1994) Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity. J Invest Dermatol 103:811-814
43. Kotenko SV, Krause CD, Izotova LS, Pollack BP, Wu W, Pestka S (1997) Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J 16:5894-5903
44. Krüger-Krasagakes S, Krasagakis K, Garbe C, Schmitt E, Hüls C, Blankenstein T, Diamantstein T (1994) Expression of interleukin 10 in human melanoma. Br J Cancer 70:1182-1185
45. Kühn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274
46. Lin TJ, Befus AD (1997) Differential regulation of mast cell function by IL-10 and stem cell factor. J Immunol 159:4015-4023
47. Liu Y, Wei SH, Ho AS, de Waal Malefyt R, Moore KW (1994) Expression cloning and characterization of a human IL-10 receptor. J Immunol 152:1821-1829
48. Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang QJ, Masucci MG, Kiessling R (1994) Interleukin 10 pretreatment protects target cells from tumorand allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 180:2371-2376
49. Michel G, Gailis A, Jarzebska-Deussen B, Muschen A, Mirmohammadsadegh A, Ruzicka T (1997) 1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells. Inflamm Res 46:32-34
50. Mitra RS, Judge TA, Nestle FO, Turka LA, Nickoloff BJ (1995) Psoriatic skin derived dendritic cell function is inhibited by exogenous IL-10. J Immunol 154:2668-2677
51. Moore KW,Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR (1990) Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248:1230-1234
52. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone, I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-2357
53. Mussi A, Bonifati C, Carducci M, Viola M, Tomaselli R, Sacerdoti G, Fazio M, Ameglio F (1994) IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids. J Biol Regul Homeost Agents 8:117-120
54. Nakajima H, Gleich GJ, Kita H (1996) Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol 156:4859-4866
55. Nickoloff BJ (1991) The cytokine network in psoriasis. Arch Dermatol 127:871-884
56. Nickoloff BJ, Fivenson DP, Kunkel SL, Strieter RM, Turka LA (1994) Keratinocyte interleukin-10 expression is upregulated in tapestripped skin, poison ivy dermatitis, and Sezary syndrome, but not in psoriatic plaques. Clin Immunol Immunopathol 73:63-68
57. Ockenfels HM, Wagner SN, Keim-Maas C, Funk R, Nussbaum G, Goos M (1996) Lithium and psoriasis: cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium. Arch Dermatol Res 288:173-178
58. Ohmen JD, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, Jullien D, McHugh T, Nassif AS, Chan SC, Modlin RL (1995) Over-expression of IL-10 in atopic dermatitis. J Immunol 154:1956-1963
59. Platzer C, Meisel C,Vogt K, Platzer M,Volk HD (1995) Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int Immunol 7:517-523
60. Pretolani M, Goldmann M (1997) IL-10:a potential therapy for allergic inflammation? Immunol Today 18:277-280
61. Reineke U, Sabat R,Volk HD, Schneider-Mergener (1998) Mapping of the Interleukin-10/Interleukin-10 receptor combining site. Protein Sci (in press)
62. Renz H, Jujo K, Bradley KL, Domenico J, Gelfand EW, Leung DY (1992) Enhanced IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J Invest Dermatol 99:403-408
63. Rode HJ, Bugert JJ, Handermann M, Schnitzler P, Kehm R, Janssen W, Delius H, Darai G (1994) Molecular characterization and determination of the coding capacity of the genome of equine herpesvirus type 2 between the genome coordinates 0.235 and 0.258 (the EcoRI DMA fragment N; 4.2 kbp). Virus Genes 9:61-75
64. Romagnani S (1995) Biology of human Th1 and Th2 cells. J Clin Immunol 15:121-129
65. Romagnani S (1996) Short analytical review. Th1 and Th2 in human diseases. Clin. Immunol Immunopathol 80:225-235
66. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A 89:1890-1893
67. Sabat R, Seifert M,Volk HD, Glaser RW (1996) Neutralizing murine monoclonal anti-interleukin-10 antibodies enhance binding of antibodies against a different epitope. Mol Immunol 33:1103-1111
68. Schlaak JF, Buslau M, JochumW, Hermann E, Girndt M, Gallati H, Meyer zum Büschenfelde KH, Fleischer B (1994) T cells involved in psoriasis vulgaris belong to the Th 1 subset. J Invest Dermatol 102:145-149
69. Schwarz A, Grabbe S, Riemann H, Yoshinori A, Simon M, Manon S, Andrade S, Luger TA, Zlotnik A, Schwarz T (1994) In vivo effects of interleukin-10 on contact hypersensitivity and delayed type hypersensitivity reactions. J Invest Dermatol 103:211-216
70. Spits H, de Waal Malefyt R (1992) Functional characterization of human IL-10. Int Arch Immunol 99:8-15
71. Stasi R, Zinzani PL, Galieni P, Lauta VM, Damasio E, Dispensa E, Dammacco F, Papa G, Tura S (1994) Prognostic value of serum IL-10 and soluble IL-2 rezeptor levels in aggressive non-Hodgkin's lymphoma. Br J Haematol 88:770-777
72. Takanaski S, Nonaka R, Xing Z, O'Byrne P, Dolovich J, Jordana M (1994) Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 180:711-715
73. Tan JC, Braun S, Rong H, DiGiacomo R, Dolphin E, Baldwin S, Narula SK, Zavodny PJ, Chou CC (1995) Characterization of recombinant extracellular domain of human interleukin-10 receptor. J Biol Chem 270:12906-12911
74. Tan JC, Indelicato SR, Narula SK, Zavodny PJ, Chou CC (1993) Characterization of interleukin-10 receptors on human and mouse cells. J Biol Chem 268:21053-21059
75. Teunissen MBM, Koomen CW, Jansen J, deWaal Malefyt R, Schmitt E, Van den Wijngaard RMJGJ, Das PK, Bos JD (1997) In contrast to their murine counterparts, normal human keratinocytes and human epidermoid cell lines A431 and HaCaT fail to express IL-10 mRNA and protein. Clin Exp Immunol 107:213-223
76. Thompson-Snipes L,DharV, Bond MW, Mosmann TR, Moore KW, Rennick DM (1991) Interleukin 10:a novel stimulatory factor for mast cells and their progenitors. J Exp Med 173:507-510
77. Uejima Y, Takahashi K, Komoriya K, Kurozumi S, Ochs HD (1996) Effect of interleukin-10 on anti-CD40-and interleukin-4-induced immunoglobulin E production by human lymphocytes. Int Arch Allergy Immunol 110:225-232
78. Van Deventer S, Elson CO, Fedorak RN (1997) Multiple doses of intravenous interleukin10 in steroid refractory Crohn's disease. Gastroenterology 113:383-389
79. Van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, Maggi-E, Romagnani-S, Westland-JK, Mudde GC (1992) Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 90:184-193
80. Vora M, Romero LI, Karasek MA (1996) Interleukin-10 induces E-selectin on small and large blood vessel endothelial cells. J Exp Med 184:821-829
81. Weber-Nordt RM, Meraz MA, Schreiber RD (1994) Lipopolysaccharide-dependent induction of IL-10 receptor expression on murine fibroblasts. J Immunol 153:3734-3744
82. Wegmann TG, Lin H, Guilbert L, Mosmann TR (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 14:353-356
83. Wierenga EA, Sillevis-Smitt JH, van der Heijden FL, Kapsenberg ML (1992) Immune dysregulation in atopic eczema. Arch Dermatol 128:1509-1512
84. Wölfer LU, Goerdt S, Schröder K, Zouboulis CC, Orfanos CE (1996) Interferon-alpha induced psoriasis. Hautarzt 47:124-128
85. Yagi H, Tokura Y, Furukawa F, Takigawa M (1996) Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-γ. J Invest Dermatol 107:827-832
86. Ying L, de Waal Malefyt R, Briere F, Parham C, Bridon JM, Banchereau J, Moore KW, Xu J (1997) The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J Immunol 158:604-613
87. Vue FY, Dummer R, Geertsen R, Hofbauer G, Laine E, Manolio S, Burg G (1997) Interleukin10 is a growth factor for human melanoma cells and down-regulates HLA class I, HLA class II and ICAM-1 molecules. Int J Cancer 71:630-637
88. Zdanov A, Schalk-Hihi C, Gustchina A, Tsang M, Weatherbee J, Wlodawer A (1995) Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. Structure 3:591-601
89. Zdanov A, Schalk-Hihi C, Menon S, Moore KW, Wlodawer A (1997) Crystal structure of Epstein-Barr virus protein BCRF1, a homolog of cellular interleukin-10. J Mol Biol 268:460-467